New antibodies have been developed to target a specific region of the influenza virus protein that is often overlooked. This region, known as the “dark side,” is crucial for the virus’s ability to infect host cells. By targeting this region, researchers hope to create more effective treatments and vaccines for influenza. The antibodies could potentially lead to a breakthrough in fighting the virus and reducing its impact on global health. The development of these antibodies represents a promising step forward in influenza research and could pave the way for innovative approaches to combating the virus.
Source link
New antibodies target “dark side” of influenza virus protein
